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Introduction
Due to its unknown etiology, pigmented villonodular synovitis 
(PVNS) had has also been termed synovial fibroendothelioma, 
chronic hemorrhagic villous synovitis, or fibrohemosideric 
sarcoma. In 1941, based on its histologic findings, Jaffe, Lich-
tenstein and Sutro first used the the term ‘PVNS’, but the path-
ogenesis is still not clear.1,2) The annual incidence of PVNS is 1.8 
patients per million in the population, which is why reporting of 
PVNS was rare in a large scale study.3-5)
    Compared to localized PVNS, diffuse-type PVNS permeates 
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to the bone and surrounding soft tissues, which results in 
destruction of major joints.2,3,5-8) The high recurrence rate after 
surgical re moval has been a major concern.2,3,6-11) Radiation or 
intra-articular radioisotope injection has been attempted to solve 
this problem, but the efficacy and indications of this method 
are still not established.2,5-7,12-18) The purpose of this study is 
to evaluate and analyze the clinical outcomes of diffuse-type 
PVNS that were treated with open synovectomy and additional 
electrocautrization. In addition, the value of radiation therapy to 
prevent recurrence is examined. 
Materials and Methods
1. Patient characteristics
From February 1994 to March 2006, 32 patients were diagnosed 
as PVNS. Histological confirmation was done in all cases. Cases 
with a follow-up of less than 3 years and localized-type were 
excluded. In all, 21 cases of diffuse-type PVNS were reviewed. 
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Purpose: Pigmented villonodular synovitis (PVNS) is a rare soft tissue tumor, which usually arises in larger joints, such as the knee. It has 
a high recurrence rate after surgical treatment. The purpose of this study is to evaluate and analyze the clinical results of diffuse-type 
pigmented villonodular synovitis cases that were treated with open total synovectomy.
Materials and Methods: Between 1994 and 2006, 21 patients who had diffuse-type pigmented villonodular synovitis were selectively 
reviewed. Among the 21 cases studied, 14 patients presented at the knee, 5 at the ankle, and 2 at the shoulder and elbow. The mean follow 
up period was 5.5 years (range, 36-157 months). The average age of the patients was 34 years consist of 7 men and 14 women. Clinical 
outcomes were analyzed retrospectively, including range of motion and complications.
Results: Open total synovectomy and adjuvant electrocautrization were done in all cases except one. During the regular follow-up period 
after the surgery, two patients showed symptoms of recurrence. After re-operation, only one case was pathologically confirmed as a 
recurrence. The patient who had partial synovectomy and the other patient who had second operation due to recur rence received additional 
radiation therapy. Clinical outcome scores were improved in every aspect (p<0.0001). 2 out of 14 Patients who had pigmented villonodular 
synovitis at the knee developed stiff knee after the surgery.
Conclusion: After the open total synovectomy with electrocautrization, a low recurrence rate and satisfactory clinical outcome was 
achieved, observed in a minimum of 3 years of follow-up.
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  1 40/F Left shoulder No Once: arthroscopy 
  92-11(YUMC)
Open total synovectomy, 
  Electrocautrization (Anterior)
(-) None   43 No
  2 38/F Right elbow No Once: arthroscopy 
  92-07 (YUMC)
Open total synovectomy, 
  Electrocautrization 
  (Anterior+posterior)
(-) None   62 No
  3 7/F Left knee No (-) Open total synovectomy, 
  Electrocautrization 
  (Popliteal fossa)
(-) None   41 No
  4 43/F Right knee No *Twice: arthroscopy 
  92-10 1st op 
  97-04 2nd op
Open total synovectomy, 
  Electrocautrization 
  (Anterior+popliteal fossa)
(-) Pain 
swelling
  41 No
  5 20/M Left knee No (-) Open total synovectomy, 
  Electrocautrization (Anterior)
(-) Pain   44 No
  6 37/F Left knee No (-) Open total synovectomy, 
  Electrocautrization 
  (Popliteal fossa)
(-) None   54 No
  7 38/F Left knee No (-) Open total synovectomy, 
  Electrocautrization (Anterior)
(-) None   78 No
  8 25/F Left knee No (-) Open total synovectomy, 
  Electrocautrization 
  (Anterior+popliteal fossa)
(-) None   87 Re-operation 
pathology 
(-)
  9 47/F Left knee No *Once: open 
  excision 01-12
Open total synovectomy, 
  Electrocautrization 
  (Anterior+popliteal fossa)
(-) None   75 No
10 31/F Right knee No (-) Open total synovectomy, 
  Electrocautrization 
  (Anterior+popliteal fossa)
(+) after 
 2nd op.
LOM   36 Yes
11 44/F Left knee No Once: arthroscopy 
  04-11 (YUMC)
Open total synovectomy, 
  Electrocautrization 
  (Popliteal fossa)
(-) None   44 No
12 15/M Left knee No *Three times: 
  arthroscopy 
  03-11 1st op 
  04-02 2nd op 
  04-10 3rd op
Open total synovectomy, 
  Electrocautrization 
  (Anterior+popliteal fossa)
(-) Stiff knee 
(0-45)
  38 No
13 42/M Left knee No Twice: open excision 
  (unknown)
Open total synovectomy, 
  Electrocautrization (Anterior)
(-) Stiff knee 
(15-70)
  36 No
14 13/M Right knee No (-) Open total synovectomy, 
  Electrocautrization (Anterior)
(-) Swelling   41 No
15 39/M Left knee No (-) Open total synovectomy, 
  Electrocautrization (Popliteal fossa)
(-) None   36 No
16 54/F Right knee No Once: open excision 
  (unknown)
Open partial synovectomy, 
  Electrocautrization (Popliteal fossa)
(+) LOM   37 No
17 42/F Right ankle No *Once: open 
  excision 95-6
Open total synovectomy, 
  Electrocautrization 
  (Anterolateral+posteromedial)
(-) None 157 No
18 42/F Left ankle No Once: open excision 
  92-09 
  (at local hospital)
Open total synovectomy, 
  Electrocautrization 
  (Anterolateral+posterolateral)
(-) None 133 No
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The medical records, age at presentation, sex, initial symptoms 
and durations, history of trauma, previous operation methods, and 
the number of operations was reviewed. The duration of follow-
up was calculated from the date of surgery to the last follow-up. 
Through the medical records and the interviews, post-operative 
complications, recurrence, and treatment details were also 
collected. The correlation between the initial treatment method 
and the recurrence was examined. During the follow-up period, 
the patients who presented clinical suspicion of recurrence, by 
symptoms, and imaging studies, underwent re-operation. The 
mean follow-up was 65 months (range, 36-157 months). There 
were seven men (33%) and fourteen women (67%), with an 
average age of 34 years (range, 7-54 years). Of the 21 patients, 
10 patients were referred for further treatment after a previous 
operation due to recurrence. 7 patients were referred from other 
hospitals after recurrences. The other 3 patients were referred 
from our arthroscopic division, and the patients had PVNS recur 
after arthroscopic removal. There was one patient who had three 
incidences of recurrence; at the each recurrence, this patient 
had arthroscopic removal. Two patients had been referred after 
two times of recurrence. One patient had arthroscopic removal, 
and the other had an open procedure. There were a total of 7 
patients who had one recurrence before the referral. Among the 
7 patients, 3 had a history of arthroscopic removal (Table 1).
 
2. Surgical method and rehabilitation
All of patients were first treated by an open synovectomy. All 
of the total synovectomy were performed by only one surgeon 
(Cor responding author). After removing as much of the syno-
vium as possible, additional electrocautrization was done at the 
base and surrounding soft tissues. There was one referral patient 
who had severe postoperative fibrosis and tethering around 
the neurovascular bundle in the popliteal fossa, which made 
it impossible to perform total synovectomy. This patient had 
additional radiation therapy after surgery. A total of 3,000 cGY 
radiation therapy was done in fifteen rounds of radiation.
    The anterior median parapatella approach and the posterior 
transpopliteal approach were used to treat 14 patients who had 
a mass at the knee. If the mass was located both anterior and 
posterior, the posterior mass was removed first, followed by 
the removal of the anterior one 6 to 8 weeks later. 5 patients 
received both the anterior and posterior surgeries. For surgery 
on the anterior, the curvilinear incision was started 1 to 2 cm 
above the superior pole of the patella, along the medial margin 
of the patella (Fig. 1B). After incising the anterior capsule, 
the synovium, including the mass, was exposed. En bloc total 
synovectomy was done when possible. The anterior cruciate 
ligament, subpatellar fat pad, medial and lateral gutter, and 
the menici was the region where careful inspection was done, 
because those are the places where the small foci of PVNS could 
be neglected.17,19) If the patient had a history of arthroscopic 
surgery, the previous entry portals were also carefully examined. 
When using the posterior approach, the prone position was used. 
The incision was began 5 cm above the joint line, at the medial 
corner of the popliteal area, and extended distally until the 
proximal portion of the gastrocnemius was exposed, such that the 
incision formed an ‘S’ shape. The popliteal artery, tibial nerve, 
and common peroneal nerve were protected during dissection 
(Fig. 1C). If possible, a branch of the sural nerve was also saved. 
Anterolateral, posterolateral, posteromedial approach were used 
to achieve total synovectomy at the ankle joint. After preserving 











19 36M Left ankle Yes (-) Open total synovectomy, 
  Electrocautrization 
  (Anterolateral+posterolateral)
(-) LOM 135 No
20 43/F Right ankle No (-) Open total synovectomy, 
  Electrocautrization 
  (Anterolateral+posterolateral)
(-) None   38 No
21 19/M Right ankle No (-) Open total synovectomy, 
  Electrocautrization 
  (Anterolateral+posteromedial)
(-) Pain   58 No
RTx, radiation therapy; Op, operation; LOM, limitation of motion; YUMC, Yonsei university college of medicine.
*Referal from other tertiary medical center.
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was retracted medially with neurovascular bundle. By incising 
proximal portion of extensor digitorum brevis and fat pad at 
Sinus tarsi, wide exposure of anterior to lateral aspect of ankle 
joint was possible including calcaneocuboid joint and medial 
half of talonavicular joint. If needed additional posterolateral 
or posteromedial approach was done after changing patient to 
the prone position (Fig. 2). There were two cases on the upper 
extremity. Anterior approach was used to remove the mass 
on the shoulder (Fig. 3) and extended posterior and anterior 
approach was used to perform total synovectomy at the elbow.
    A posterior splint was applied immediately after operation, and 
removed 2-4 days later when the drain was removed. Rehabili-
tation started with passive range of motion (ROM) exercises and 
vigorous active assisted ROM exercises were done by a physio-
therapist for 1 month. Especially for the patient who had a sur-
gery at knee, quadriceps strengthening exercises, while sitting on 
a bed or chair was emphasized.
3. Assessment
Regular follow-up was done after the surgery at 2 months, 4 
months, 6 months, and annually. At every annual follow-up, the 
functional clinical outcome was assessed by checking pain, range 
of motion, symptoms, and activity of daily living (ADL), which 
was suggested by Ogilvie-Harris,20) as modified from Laurin’s 
proposal (Table 2). We compared scores a 3 year follow-up pe-
riod to pre-operative scores. Recent symptoms and satisfaction 
with the surgery were checked by telephone interviews.
    SAS v. 9.1 (SAS Inc., North Carolina), the chi-square test, 
the paired t-test, and one-way ANOVA were used for statistical 
analysis.
Results
There were 7 male and 14 female patients. Females were pre-
dominant in a two to one ratio, but this was not statistically sig-
nificant (p=0.126). The knee joint was the most commonly oc-
curring site (14 cases), followed by 5 cases at the ankle joint, and 
2 cases at the upper extremity. 14 patients (66%) complained of a 
palpable mass at the presentation, which was the most common 
symptom (Table 3). Only the one patient had a history of trauma 
before the initiation of symptoms.
    During the follow-up period, which was a mean of 65 months 
Figure 1. MRI and gross photos representing the diffuse type PVNS located in anterior and posterior aspect of the knee. (A) Pre-operative MRI 
revealing diffuse mass on anterior and posterior aspect of the knee. (B) Intra-operative findings after an anterior medial para patella approach. (C) 
Intra-operative findings after a posterior popliteal approach. (D) Gross photo of pathology.
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(range, 36-157 months), two patients had a clinical suspicion 
of recurrence. Both suspected recurrences had symptoms of 
swelling and pain. Follow-up MRI revealed equivocal findings 
to the previous operation field, so re-operation was done. 
Histologic confirmation was also done to identify recurrence 
after the re-operation. Of the two patients, only one patient 
showed histologic confirmation of recurrence. This patient 
had radiation therapy after re-operation. The other patient 
presented non-specific chronic synovial inflammation, which 
resolved after 3 months of conservative treatment. The functional 
clinical outcome assessment, as suggested by Ogilvie-Harris, 
showed improvement in all aspects after the surgery (Table 
4). By comparing scores from 3 years post-operative to pre-
operative scores, pain (p=0.0001), swelling (p=0.0009), range of 
motion (p=0.0004), function (p＜0.0001), and total (p＜0.0001) 
scores showed statistically significant improvement. 11 patients 
(10: referral from other hospitals, 1: received initial surgery by 
the author) who had re-operation due to recurrence presented 
overall low scores in all the categories, as compared to the other 
patients, though the scores were not statistically significant (pain: 
p=0.844, swelling: p=0.656, range of motion: p=0.662, function: 
p=0.819, total: p=0.984). In comparing the patients who had 
recurrences, those who had more than two recurrences showed 
decreased range of motion (p=0.043). Other categories did not 
show statistical significance. At the last follow-up, two patients 
had a range of motion less than 90 degrees, which restrains 
their daily living. Four other patients complained of intermittent 
swelling and pain, though the rest of the patients did not have 
Figure 2. A 36 year old male who had 
diffuse-type PVNS in his left ankle. (A) Pre-
operative x-ray presenting radiolucent 
lesions on distal fibular and tibia. (B) Pre-
operative MRI images showing diffuse 
mass on anterior and posterior aspect 
of the ankle. (C) Intra-operative gross 
findings after a posterolateral approach. 
(D) Microscopic findings present synovial-
like mononuclear cells, hemosiderin laden 
macrophages, foam cells and giant cells 
which are consistent findings of PVNS 
(H&E stain).
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any complications that interfered with their living.
Discussion
Pigmented villonodular synovitis (PVNS) generally occurs in 
patients in the third or fourth decade of life.1-4,10,14) The average 
age of a patient in this study was 34 years, which matched the 
Figure 3. Representive plain radiography, 
MRI and Microscopic findings of diffuse-
type PVNS in shoulder joint. (A) Pre-
operative plain radiography presenting 
radiolucent lesion and bony erosions on 
glenohumeral joint. (B) Pre-operative 
MRI images (axial) presenting infiltrative 
diffuse mass on glenohumeral joint with 
bony erosion and cysts. (C) Microscopic 
findings present hypertrophied synovium, 
foam cells, giant cells which are consistent 
findings of PVNS (H&E stain).
Table 2. Criteria for Assessment Proposed by Ogilvie-Harris 
0 1 2 3
  Pain Severe Moderate Slight None
  Synovitis/swelling Severe Moderate Slight None
  ROM More than 20% loss 10% to 20% loss 0% to 10% loss Normal
  Function Minimal activity Reduced activity Almost complete activity Complete activity
Table 3. Preoperative Symptoms
Symptom No. of patients
Palpable mass 14 (66%)
Pain 11 (52%)
Swelling   7 (33%)
LOM 2 (9%)
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average age of a previous study. The knee and flexor tendon 
sheaths of the hand are the most frequent occurring site compare 
to ankle and shoulder.1,4-6,10,21) In this study, 66% (14 cases) oc-
curred at the knee.
    According to Myers and Masi,4) the distribution of PVNS by 
sex is close to two to one, with a predominance in male patients. 
Our study, however, showed a predominance of female cases, 
by two to one (female: 14 cases, male: 7 cases). Considering that 
there is also a report of the distribution being equal or opposite, a 
larger scale study should be done.4,10,14)
    Palpable mass was the most common symptom at first presen-
tation (66%); only 9% of the patients complained of limitation of 
motion as the initial symptom. It should be noted that if the mass 
locates in the popliteal fossa or ankle, it is easy to palpate. In the 
previous report, swelling and pain were the common presenting 
symptoms.2,6,10)
    Even though there is a hypothesis that intra-articular hemor-
rhage due to recurrent trauma is the cause of PVNS, many studies 
report that there is little connection between trauma and etiology 
of PVNS.2,4,5,10,22) In this study, there was only one patient who 
had a history of trauma before the initiation of symptoms.
    Several authors have insisted on less extensive approaches 
for the treatment of diffuse PVNS, but there are reasons why an 
extensive approach or radical synovectomy with a safe margin 
has been advocated by many authors, treating PVNS like other 
malignancy.2,5-7,11,13-15,17,19,21,22) Although the pathogenesis of 
PVNS is still unclear, Bertoni et al.23) reported characteristics of 
a malignant form PVNS in 8 cases, and Oda et al.24) published 
Table 4. Result of Clinical Assessment
No Site
Pain Swelling ROM Function Total
Pre Post Pre Post Pre Post Pre Post Pre Post 
1 Shoulder 0 3 2 2 1 2 0 2   3   9  
2 Elbow 2 3 2 3 0 3 1 3   5 12
   Mean 1 3 2 2.5 0.5 2.5 0.5 2.5   4 10.5
3 Knee 0 3 1 2 2 3 1 3   4 11
4 Knee 0 2 0 1 2 2 1 2   3   7
5 Knee 0 1 2 3 1 2 2 2   5   8
6 Knee 0 3 3 3 2 2 2 3   7 11
7 Knee 3 3 3 3 2 3 3 3 11 12
8 Knee 3 3 2 3 2 3 2 3   9 12
9 Knee 1 2 2 2 2 3 2 2   7   9
10 Knee 2 3 2 3 0 1 1 2   5   9
11 Knee 1 2 3 3 2 3 2 3   8 11
12 Knee 2 2 0 2 2 1 1 1   5   6
13 Knee 0 1 1 1 1 1 1 1   3   4
14 Knee 1 2 2 1 2 3 2 3   7   9
15 Knee 3 3 2 3 2 3 2 3   9 12
16 Knee 2 2 2 2 1 1 2 2   7   7
   Mean 1.29 2.29 1.79 2.29 1.64 2.21 1.71 2.36   6.43   9.14 
17 Ankle 0 2 0 1 0 2 0 1   0   6
18 Ankle 2 2 0 1 2 2 2 2   6   7
19 Ankle 1 2 2 2 0 1 0 1   3    6
20 Ankle 1 2 1 2 1 3 2 3   5 10
21 Ankle 1 1 1 2 1 1 1 1   4   5
   Mean 1 1.8 0.8 1.6 0.8 1.8 1 1.6   3.6   6.8
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a case presenting a malignant transformation of PVNS at the 
sacrum, following two recurrences. These findings demonstrate 
that careful attention should be paid to PVNS, due to its potential 
for malignant behavior. Using a DNA microarray, Finis et al.25) 
described that PVNS had a decreased apoptotic cell cycle, like 
other malignancies. Layfield et al.26) found trisomies in the 
fifth and seventh chromosomes within tissue of PVNS. These 
recent findings about cytogenetic abnormalities, in the form of 
monoclonalities and chromosomal abnormalities, supports the 
malignant pathogenesis of PVNS. Addition to that, clinical findings 
of its local invasiveness, destruction of major joints, and frequent 
recurrence after the surgery have been the most concerning 
problems when dealing with PVNS.6-8,11,14,17,19,22) Recurrence rate 
after surgery is reported in 8-48% of patients when diffuse-type 
PVNS occurs at knee.2,3,5,9-11) When PVNS is in the hand, the 
reported recurrence rate varies from 7-45%.2,3,16) There have been 
several reports of a low recurrence rate when arthroscopy and 
adjuvant radiation therapy are used, although those methods are 
generally considered to be appropriate for treating the localized 
form or biopsy.17,20,27)
    Due to the limitation of surgical exposure, arthroscopic 
removal is not suitable for diffuse-type or extra-articular type 
PVNS, as in the patients in this study.17,19) 47% (10 cases) of 
the patients were referred because of recurrence after primary 
surgery. Among the 10 cases, 50% had previous arthroscopic 
removal. Considering that repeated surgery increases the chance 
of morbidity, such as a stiff knee, a complete resection of the 
pathologic mass in the initial surgery is the best method to ensure 
a good prognosis. 
    The risk that extensive open surgical approaches to the 
joint will increase post-operative morbidities, such as a stiff 
joint, or the possibility of infection, has led surgeons to hesitate 
before performing open procedures, which made them to try 
minimally invasive techniques for the resection of diffuse-
type PVNS, such as arthroscopic removal.20,27) Sharma et al.22) 
has reported satisfactory clinical outcomes with low recurrence 
rate, and preservation of knee joint function, after more than 6 
years of follow-up using open synovectomy. Chin et al.17) has 
also reported similar clinical outcomes after open surgery. It is 
thought that insufficient resection leads to recurrence, and that 
frequent surgery cause functional impairment of the joint. In this 
study, there were two patients who had a stiff knee after surgery, 
with a range of motion less than 90 degrees. Both of the patients 
had more than two re-operations, due to recurrence. The other 
patients did not have functional impairment after surgery, and 
there was improvement in every aspect of the clinical assessment. 
Additionally, it was determined by telephone interview that 
if patients were satisfied with the surgical results, they have 
decreased anxiety about recurrence.
    There have been reports of satisfactory results from radia tion 
therapy as adjuvant therapy, though radiation has drawbacks.12,16) 
There is the possibility of sarcomatous change after radiation or 
post-radiation fibrosis, which might obscure findings of recur-
rence. These changes also increase the difficulty of re-operation. 
Bickels et al.18) reported full thickness necrosis after using the 
radio isotope Yttrium-90 in a patient with PVNS of the ankle 
joint, which led to a cessation of the use of radioisotopes for ad-
juvant therapy. 
    Although it needs demanding surgical skills to perform total 
synovectomy, there were satisfactory surgical outcomes without 
radiation therapy with the condition that complete resection 
with a total synovecmy.5,7,14,15,22) Atmore et al.13) and Kotwal et 
al.16) both reported that compared to surgery alone, adjuvant 
radiation therapy is not advantageous. Flandry et al.15) reported 
that it is not necessary to perform additional radiation therapy if 
total synovectomy is done. According to these reports, adjuvant 
radiation therapy should not be a routine procedure, if a surgeon 
performs adequate total synovectomy. We limited radiation 
therapy to patients with recurrence after total synovectomy, or 
those who had subtotal synovectomy. 
    We performed total synovectomy on all patients when it was 
possible, which resulted in all but one having total synovectomy, 
as for that patient it was impossible to perform total synovectomy 
due to anatomic reasons. Additional electrocautrization was 
done at the base and surrounding soft tissues instead of radiation 
therapy. We expected the thermal effect of electrocautrization 
to remove remnant pathology. During the follow-up period, 
of an average of 65 months, there was one (8.3%) recurrence 
at the knee. It was pathologically confirmed and re-operation 
was done, and a total of 3,000 cGy of radiation therapy was also 
applied. Similar to the Chin et al.17) and Sharma et al.22) reports, 
our study shows a comparably low recurrence rate without using 
radiation therapy. 
  Considering there is no established treatment protocol for 
diffuse-type PVNS, our surgical outcome supports that complete 
total synovectomy at initial operation is the key step in successful 
treatment. 
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미만형 색소 융모 결절성 활액막염의 관혈적 활막 전 절제술 후 경과
이모세 • 이수현 • 서진석* • 양우익† • 신규호
연세대학교 의과대학 정형외과학교실, *영상의학교실, †병리학교실
목적: 색소 융모 결절성 활액막염은 슬관절을 비롯한 주요 관절에서 드물게 발생하는 연부 조직 종양으로서 수술 적 치료 후 재발 빈도가 
높은 것으로 알려져 있다. 본 연구에서는 주요 관절에 발생한 미만형 색소 융모 결절성 활액막염에 대한 활막 전 절제술 후 임상 경과를 
보고하고, 기존에 발표 된 문헌과 비교 분석하고자 한다.
대상 및 방법: 1994년 2월부터 2006년 3월까지 미만형 색소 융모 결절성 활액막염으로 치료 받은 21예의 환자를 대상으로 하였으며, 발
생 부위는 슬관절 14예, 족관절 5예, 견주관절 2예가 있었다. 평균 추시 기간은 5년 5개월이었다(36-157개월). 발생 연령은 평균 34세였
으며 남자가 7명, 여자가 14명이었다. 후향적 연구 방법으로 관절 운동 범위 측정을 포함한 정기적인 임상 양상 평가를 하였다.
결과: 총 21예의 미만형 환자 중 1예를 제외 한 전례에서 활막 전 절제술 및 전기소작술을 통한 보강 치료를 시행 하였으며, 정기적인 외래 
경과 관찰 상 재발이 의심 되었던 2예에서 재수술 후, 1예에서만 조직학적 재발이 확진 되었다. 활막 전 절제술을 시행 하지 못한 1예와, 재
발로 재수술 받은 1예에서 술 후 방사선 치료를 시행 하였다. 임상 기능 평가상 술전과 비교하여 모든 부분에서 통계적으로 유의한 호전이 
있었다(p＜0.0001). 슬관절에 발생한 병변으로 수술적 치료를 시행 후 관절 운동 장애로 제약이 있던 환자는 2예(총 14예) 있었다.
결론: 최소 3년 이상의 추시 기간 동안 활막 전 절제술 및 전기 소작술을 통한 보강 치료로 호전된 임상 결과 및 낮은 재발율의 치료 효과
를 얻을 수 있었다. 잦은 재발과 주요 관절에 발생하여 국소적 침투, 파괴로 기능 장애를 일으키는 미만형 색소 융모 결절성 활액막염에 
치료에 있어 적절한 활막 전 절제술이 시행 될 경우 방사선 보강 치료는 제한 된 경우에만 필요할 것이다.
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